Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Edmonds, WA
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Edmonds, WA
Click here to add this to my saved trials
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Olympia, WA
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Olympia, WA
Click here to add this to my saved trials
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Spokane, WA
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Wenatchee, WA
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Wenatchee, WA
Click here to add this to my saved trials
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Calgary,
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Calgary,
Click here to add this to my saved trials
Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Early Vs Late Sirolimus-Initiation Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Status: Enrolling
Updated:  1/23/2017
Cardiology Division, University of Minnesota
mi
from
Minneapolis, MN
Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Early Vs Late Sirolimus-Initiation Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Status: Enrolling
Updated: 1/23/2017
Cardiology Division, University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Phase IB Double Blind, Randomized, Placebo Controlled Clinical Trial to Determine the Pharmacokinetics and Safety of a Revised Protocol of Intravenous L-Citrulline (Citrupress®) Versus Placebo in Children Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated:  1/23/2017
Washington University Children's Hospital
mi
from
St. Louis, MO
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Phase IB Double Blind, Randomized, Placebo Controlled Clinical Trial to Determine the Pharmacokinetics and Safety of a Revised Protocol of Intravenous L-Citrulline (Citrupress®) Versus Placebo in Children Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated: 1/23/2017
Washington University Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Phase IB Double Blind, Randomized, Placebo Controlled Clinical Trial to Determine the Pharmacokinetics and Safety of a Revised Protocol of Intravenous L-Citrulline (Citrupress®) Versus Placebo in Children Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated:  1/23/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Phase IB Double Blind, Randomized, Placebo Controlled Clinical Trial to Determine the Pharmacokinetics and Safety of a Revised Protocol of Intravenous L-Citrulline (Citrupress®) Versus Placebo in Children Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated: 1/23/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)
Phase I, Non-Randomized, Feasibility Study for the Use of Bone Marrow Cell Concentrate Prepared Using the Magellan System for the Treatment of Critical Limb Ischemia
Status: Enrolling
Updated:  1/23/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)
Phase I, Non-Randomized, Feasibility Study for the Use of Bone Marrow Cell Concentrate Prepared Using the Magellan System for the Treatment of Critical Limb Ischemia
Status: Enrolling
Updated: 1/23/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Follow Up on Freestyle Valves in Children
Follow Up on Freestyle Valves for Right Ventricular Outflow Tract Reconstruction in Children
Status: Enrolling
Updated:  1/25/2017
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Follow Up on Freestyle Valves in Children
Follow Up on Freestyle Valves for Right Ventricular Outflow Tract Reconstruction in Children
Status: Enrolling
Updated: 1/25/2017
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Bakersfield Memorial Hospital
mi
from
Bakersfield, CA
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Bakersfield Memorial Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Mt Sinai Medical Center
mi
from
Miami Beach, FL
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Mt Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Emory University Hospital
mi
from
Atlanta, GA
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Heart Center of Indiana
mi
from
Indianapolis, IN
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Louisiana Heart Hospital
mi
from
Lacombe, LA
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Louisiana Heart Hospital
mi
from
Lacombe, LA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Deborah Heart & Lung Center
mi
from
Brown Mills, NJ
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Deborah Heart & Lung Center
mi
from
Brown Mills, NJ
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Lenox Hill Hospital
mi
from
New York, NY
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Southern Oregon Cardiology, LLC
mi
from
Medford, OR
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Southern Oregon Cardiology, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Cardiology Consultants of Texas
mi
from
Dallas, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Cardiology Consultants of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Plaza Medical Center
mi
from
Fort Worth, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Plaza Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Houston Methodist Hospital
mi
from
Houston, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Texas Cardiac Center
mi
from
Lubbock, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Texas Cardiac Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
The Heart Hospital Baylor Plano
mi
from
Plano, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Tyler Cardiovascular Consultants
mi
from
Tyler, TX
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Tyler Cardiovascular Consultants
mi
from
Tyler, TX
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Virginia Cardiovascular Specialists
mi
from
Richmond, VA
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Virginia Cardiovascular Specialists
mi
from
Richmond, VA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Aspirus Heart & Vascular Institute
mi
from
Wausau, WI
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Aspirus Heart & Vascular Institute
mi
from
Wausau, WI
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
St Joseph's Hospital
mi
from
Liverpool, NY
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
St Joseph's Hospital
mi
from
Liverpool, NY
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Mount Sinai Hosp
mi
from
New York, NY
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
York General Hospital
mi
from
York, PA
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
York General Hospital
mi
from
York, PA
Click here to add this to my saved trials
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated:  1/30/2017
Clinique Axium
mi
from
Aix en Provence,
The PzF Shield Trial
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy
Status: Enrolling
Updated: 1/30/2017
Clinique Axium
mi
from
Aix en Provence,
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
Ochsner Health System
mi
from
New Orleans, LA
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
Ochsner Health System
mi
from
New Orleans, LA
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
Cleveland Clinic
mi
from
Cleveland, OH
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
CHI ST. Luke's - Baylor St. Lukes Medical Center / Texas Heart Institute
mi
from
Houston, TX
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
CHI ST. Luke's - Baylor St. Lukes Medical Center / Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
Houston Methodist Hospital
mi
from
Houston, TX
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
Baylor College of Medicine
mi
from
Houston, TX
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated:  1/30/2017
Aurora Health Care
mi
from
Milwaukee, WI
Development & Testing of a Decision Aid for LVAD Placement
Development and User Testing of a Decision Aid for Left Ventricular Assist Device (LVAD) Placement
Status: Enrolling
Updated: 1/30/2017
Aurora Health Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated:  1/30/2017
Clinical Research Facility
mi
from
La Jolla, CA
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated: 1/30/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated:  1/30/2017
Clinical Research Facility
mi
from
San Diego, CA
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated: 1/30/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated:  1/30/2017
Clinical Research Facility
mi
from
Kansas City, MO
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated: 1/30/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated:  1/30/2017
Clinical Research Facility
mi
from
New York, NY
A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled
Status: Enrolling
Updated: 1/30/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Status: Enrolling
Updated:  1/31/2017
Albert Einstein Healthcare Network
mi
from
Philadelphia, PA
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Status: Enrolling
Updated: 1/31/2017
Albert Einstein Healthcare Network
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Status: Enrolling
Updated:  1/31/2017
Albert Einstein Healthcare Network
mi
from
Philadelphia, PA
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis
Status: Enrolling
Updated: 1/31/2017
Albert Einstein Healthcare Network
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates
Status: Enrolling
Updated:  1/31/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates
Status: Enrolling
Updated: 1/31/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
The Use of Optical Oximetry in Determining Gastrointestinal Complications After the Hybrid Procedure
Status: Enrolling
Updated:  1/31/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
The Use of Optical Oximetry in Determining Gastrointestinal Complications After the Hybrid Procedure
Status: Enrolling
Updated: 1/31/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
"A Phase II Open-Label, Non-Randomized, Single-Center Trial to Determine the Optimal Myocardial Perfusion Image Acquisition Time Following BMS068645 Administration
Status: Enrolling
Updated:  1/31/2017
Local Institution
mi
from
New York, NY
A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
"A Phase II Open-Label, Non-Randomized, Single-Center Trial to Determine the Optimal Myocardial Perfusion Image Acquisition Time Following BMS068645 Administration
Status: Enrolling
Updated: 1/31/2017
Local Institution
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography
A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography
Status: Enrolling
Updated:  1/31/2017
Local Institution
mi
from
Birmingham, AL
A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography
A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography
Status: Enrolling
Updated: 1/31/2017
Local Institution
mi
from
Birmingham, AL
Click here to add this to my saved trials